Publications by authors named "Sonja Praprotnik"

Claim this Profile
I
Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis.
Lucía Delgado, Alejandra Flores-Chávez, Antónia Szántó, Roberta Priori, Hendrika Bootsma, Sonja Praprotnik

Clin Exp Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients.
Pilar Brito-Zerón, Alejandra Flores-Chávez, Ildiko Fanny Horváth, Roberta Priori, Hendrika Bootsma, Sonja Praprotnik

Clin Exp Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis.
Pilar Brito-Zerón, Alejandra Flores-Chávez, Wan-Fai Ng, Ildiko Fanny Horváth, Astrid Rasmussen, Sonja Praprotnik

Clin Exp Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.
Alejandra Flores-Chávez, Pilar Brito-Zerón, Wan-Fai Ng, Antónia Szántó, Astrid Rasmussen, Sonja Praprotnik

Clin Exp Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.
Pilar Brito-Zerón, Alejandra Flores-Chávez, Ildiko Fanny Horváth, Astrid Rasmussen, Xiaomei Li, Sonja Praprotnik

EClinicalMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Gabriela Hernández-Molina, Belchin Kostov, Pilar Brito-Zerón, Arjan Vissink, Thomas Mandl, Sonja Praprotnik

Rheumatology (Oxford)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.
Nevsun Inanc, Belchin Kostov, Roberta Priori, Alejandra Flores-Chavez, Francesco Carubbi, Sonja Praprotnik

Clin Exp Rheumatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PR3-ANCA vasculitis as manifestation of ASIA syndrome following aesthetic breast augmentation: a new kid on the block?
Blaž Burja, Alojzija Hočevar, Daja Šekoranja, Katarina Živec, Žiga Rotar, Sonja Praprotnik

Clin Exp Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.
Soledad Retamozo, Nihan Acar-Denizli, Ildiko Fanny Horváth, Wan-Fai Ng, Astrid Rasmussen, Sonja Praprotnik

Clin Exp Rheumatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Sonja Praprotnik, Matija Tomsic

Clin Exp Rheumatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.
Pilar Brito-Zerón, Sandra G Pasoto, Angel Robles-Marhuenda, Thomas Mandl, Arjan Vissink, Sonja Praprotnik

Clin Exp Rheumatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Nihan Acar-Denizli, Ildiko-Fanny Horváth, Thomas Mandl, Roberta Priori, Arjan Vissink, Sonja Praprotnik

Clin Exp Rheumatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
Pilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, Ildiko Fanny Horváth, Astrid Rasmussen, Sonja Praprotnik

Rheumatology (Oxford)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells.
Manca Ogrič, Katjuša Mrak Poljšak, Katja Lakota, Polona Žigon, Sonja Praprotnik

Atherosclerosis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
Soledad Retamozo, Nihan Acar-Denizli, Astrid Rasmussen, Ildikó Fanny Horváth, Chiara Baldini, Sonja Praprotnik

Clin Exp Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
Sonja Praprotnik, Alojzija Hočevar, Žiga Rotar, Matija Tomšič, Nataša Gašperšič

Rheumatology (Oxford)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.
Nadja Kobold, Barbara Jenko, Matija Tomšič, Vita Dolžan, Sonja Praprotnik

Isr Med Assoc J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA.
Manca Ogrič, Polona Žigon, Katja Lakota, Sonja Praprotnik, David Drobne

Clin Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Polona Žigon, Anuška Podovšovnik, Aleš Ambrožič, Matija Tomšič, Alojzija Hočevar, Sonja Praprotnik

Clin Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients.
Blaž Burja, Julia Feichtinger, Katja Lakota, Gerhard G Thallinger, Snezna Sodin-Semrl, Sonja Praprotnik

Clin Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioRx.si.
Žiga Rotar, Matija Tomšič, Sonja Praprotnik,

Clin Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels.
Manca Ogrič, Polona Žigon, David Drobne, Borut Štabuc, Snezna Sodin-Semrl, Sonja Praprotnik

Immunol Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
Pilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, Margit Zeher, Astrid Rasmussen, Sonja Praprotnik

Clin Exp Rheumatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.
Tadeja Kuret, Katja Lakota, Polonca Mali, Saša Čučnik, Sonja Praprotnik

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.
Barbara Jenko, Matija Tomšič, Biljana Jekić, Vera Milić, Vita Dolžan, Sonja Praprotnik

Front Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis